Home > Financial Ratios > LYKA LABS

LYKA LABS
Cash Earnings per Share (CEPS)

    Back to All Ratios
AD     Remove this Ad

LYKA LABS Last 5 Year Cash Earnings per Share (CEPS) History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   CEPS(Rs) 4.123.080.3219.45-0.62

What is the latest Cash Earnings per Share (CEPS) ratio of LYKA LABS ?

The latest Cash Earnings per Share (CEPS) ratio of LYKA LABS is 4.12 based on Mar2025 Consolidated results.
Year Cash Earnings per Share (CEPS)
Mar20254.12
Mar20243.08
Mar20230.32
Mar202219.45
Mar2021-0.62

How is Cash Earnings per Share (CEPS) of LYKA LABS Trending?

Years Cash Earnings per Share (CEPS) % Change
Mar2025 4.12
33.77
Mar2024 3.08
862.50
Mar2023 0.32
-98.35
Mar2022 19.45
Positive
Mar2021 -0.62 -

Other Financial Ratios of LYKA LABS


Compare Cash Earnings per Share (CEPS) ratio of peers of LYKA LABS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
LYKA LABS ₹207.5 Cr 7.5% 0.5% -45.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹397,018.0 Cr -2.3% -8.5% -3% Stock Analytics
DIVIS LABORATORIES ₹162,454.0 Cr 5.3% -3.4% 3.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹140,702.0 Cr 3.7% -4.9% 26% Stock Analytics
DR REDDYS LABORATORIES ₹102,830.0 Cr 1.2% -4.2% 5.3% Stock Analytics
CIPLA ₹99,325.0 Cr 2.4% -7.2% -18.1% Stock Analytics


LYKA LABS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
LYKA LABS

7.5%

0.5%

-45.6%

SENSEX

5.8%

-1.7%

1.2%


You may also like the below Video Courses